HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Hashimoto Selected Research

5- (3- methoxyphenyl)- 3- (5- methyl- 1,2,4- oxadiazol- 3- yl)- 2- oxo- 1,2- dihydro- 1,6- naphthyridine

4/2014In vivo pharmacological characterization of AC-3933, a benzodiazepine receptor partial inverse agonist for the treatment of Alzheimer's disease.
1/2014Pharmacological properties of AC-3933, a novel benzodiazepine receptor partial inverse agonist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Hashimoto Research Topics

Disease

68Pemphigus (Pemphigus Vulgaris)
01/2020 - 01/2000
45Bullous Pemphigoid (Pemphigoid)
01/2021 - 01/2000
32Neoplasms (Cancer)
01/2019 - 01/2000
14Skin Diseases (Skin Disease)
03/2022 - 05/2000
12Blister (Bulla)
12/2017 - 01/2000
11Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa)
04/2019 - 11/2001
10Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis)
01/2017 - 07/2000
8Carcinoma (Carcinomatosis)
06/2008 - 01/2000
7Infections
11/2008 - 04/2000
6Linear IgA Bullous Dermatosis
11/2016 - 12/2000
6Schizophrenia (Dementia Praecox)
02/2008 - 05/2000
5Inflammation (Inflammations)
01/2019 - 02/2000
5Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid)
03/2014 - 01/2000
5Psoriasis (Pustulosis Palmaris et Plantaris)
06/2013 - 06/2000
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2003 - 07/2000
4Acantholysis
01/2019 - 01/2000
4Cicatrix (Scar)
12/2017 - 02/2000
4Alzheimer Disease (Alzheimer's Disease)
04/2014 - 11/2000
4Autistic Disorder (Autism)
07/2011 - 09/2000
4Insulin Resistance
02/2006 - 01/2000
4Adenocarcinoma
08/2001 - 02/2000
4Seizures (Absence Seizure)
07/2001 - 05/2000
4Heart Failure
07/2001 - 04/2000
3Disease Progression
10/2016 - 05/2001
3Bronchiolitis Obliterans
12/2015 - 02/2000
3Hypersensitivity (Allergy)
11/2015 - 04/2000
3Thymoma (Thymic Carcinoma)
07/2015 - 08/2000
3Atherosclerosis
01/2014 - 01/2000
3Respiratory Insufficiency (Respiratory Failure)
06/2013 - 02/2000
3Hemorrhage
04/2010 - 09/2004
3Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa)
05/2009 - 11/2000
3Necrosis
04/2004 - 07/2000
3Lung Neoplasms (Lung Cancer)
03/2003 - 02/2000
3Hypertension (High Blood Pressure)
02/2002 - 09/2000
3Chronic Pancreatitis
12/2001 - 10/2000
3Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation)
11/2001 - 10/2000
3Myocardial Infarction
11/2001 - 03/2000
2Atopic Dermatitis (Atopic Eczema)
11/2022 - 05/2003
2Ischemic Stroke
01/2022 - 08/2000
2Castleman Disease (Castleman's Disease)
01/2017 - 04/2016
2Alcoholism (Alcohol Abuse)
01/2016 - 09/2015
2Pneumonia (Pneumonitis)
01/2016 - 10/2007
2Sclerosing Cholangitis
11/2015 - 06/2001

Drug/Important Bio-Agent (IBA)

54AutoantibodiesIBA
01/2020 - 01/2000
42Immunoglobulin G (IgG)IBA
04/2019 - 01/2000
36AntibodiesIBA
01/2020 - 01/2000
33Immunoglobulin A (IgA)IBA
01/2017 - 01/2000
18Proteins (Proteins, Gene)FDA Link
04/2019 - 01/2000
18AntigensIBA
06/2013 - 01/2000
17DesmocollinsIBA
07/2016 - 11/2000
15EnzymesIBA
12/2017 - 05/2000
14ImmunosorbentsIBA
12/2017 - 05/2000
12Desmoglein 1IBA
07/2015 - 01/2000
11DesmogleinsIBA
07/2015 - 01/2001
10AutoantigensIBA
01/2019 - 06/2000
8Pharmaceutical PreparationsIBA
03/2022 - 11/2000
8EpitopesIBA
01/2017 - 11/2000
8Messenger RNA (mRNA)IBA
01/2008 - 09/2000
7Adrenal Cortex Hormones (Corticosteroids)IBA
05/2014 - 01/2000
6KalininIBA
01/2019 - 01/2000
6Collagen Type VIIIBA
12/2017 - 11/2000
6Prednisolone (Predate)FDA LinkGeneric
06/2013 - 10/2000
5Recombinant ProteinsIBA
07/2015 - 01/2001
5DNA (Deoxyribonucleic Acid)IBA
02/2008 - 01/2000
4Laminin (Merosin)IBA
01/2021 - 01/2011
4Matrix Metalloproteinases (MMPs)IBA
01/2019 - 12/2009
4CollagenIBA
01/2018 - 11/2015
4Immunoglobulin E (IgE)IBA
07/2017 - 11/2001
4Desmoglein 3IBA
07/2016 - 11/2000
4RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2008 - 08/2000
4Fatty Acids (Saturated Fatty Acids)IBA
02/2006 - 02/2000
3Cadherins (E-Cadherin)IBA
07/2015 - 03/2000
3Cholinergic Agents (Cholinergics)IBA
04/2014 - 04/2000
3DapsoneFDA Link
05/2007 - 11/2001
3Lansoprazole (Prevacid)FDA LinkGeneric
07/2005 - 07/2000
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2004 - 08/2001
3Immunoglobulins (Immunoglobulin)IBA
01/2004 - 07/2000
3Peptides (Polypeptides)IBA
05/2003 - 11/2000
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2001 - 08/2000
3Glucose (Dextrose)FDA LinkGeneric
09/2001 - 08/2000
3AcidsIBA
09/2001 - 04/2000
3PPAR alphaIBA
01/2001 - 09/2000
2SaltsIBA
04/2019 - 01/2011
2Collagen Type IV (Type IV Collagen)IBA
01/2017 - 03/2013
2ParaffinIBA
10/2016 - 07/2001
2Anti-Bacterial Agents (Antibiotics)IBA
01/2016 - 04/2000
2IntegrinsIBA
02/2015 - 12/2014
2Intravenous Immunoglobulins (IVIG)FDA Link
10/2014 - 06/2013
2envoplakinIBA
09/2014 - 04/2001
2Rituximab (Mabthera)FDA Link
06/2014 - 01/2013
2GABA-A Receptors (GABA(A) Receptor)IBA
04/2014 - 02/2008
25- (3- methoxyphenyl)- 3- (5- methyl- 1,2,4- oxadiazol- 3- yl)- 2- oxo- 1,2- dihydro- 1,6- naphthyridineIBA
04/2014 - 01/2014

Therapy/Procedure

24Therapeutics
01/2022 - 02/2000
7Drug Therapy (Chemotherapy)
08/2018 - 10/2000
4Aftercare (After-Treatment)
07/2009 - 11/2000
4Pallidotomy
11/2003 - 02/2001
4Liver Transplantation
09/2001 - 11/2000
3Thoracotomy
01/2013 - 12/2004
2Injections
02/2016 - 10/2000
2Home Nursing (Nursing, Home)
09/2015 - 07/2011